Key Metrics
6.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q2
Genetics
SJR
- Q2 Genetics
- Q1 Pharmacology
- Q2 Molecular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.07
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Central nervous system
- Complex disease
- Breast cancer
- Assay
- Cerebrospinal fluid
- Whole blood
- Confidence interval
- Differential expression
- Azoospermia
- HPV DNA detection
- Psoriasis
- Antisense oligonucleotides
- Hazard ratio
- Genotype
- Germ cell tumors
- Peripheral blood
- Molecular analysis
- Colorectal cancer
- Precision medicine
- Pathophysiology
Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Molecular Diagnosis and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Acknowledgement to Referees
- 1 Jan 24
- Molecular Diagnosis & Therapy
-
Full paper
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
- 1 Mar 23
- Molecular Diagnosis & Therapy
-
Full paper
Lutetium Lu 177 Vipivotide Tetraxetan: First Approval
- 13 May 22
- Molecular Diagnosis & Therapy
-
Full paper
Ongoing Challenges in the Diagnosis of 11p15.5-Associated Imprinting Disorders
- 1 May 22
- Molecular Diagnosis & Therapy
-
Full paper
Acknowledgement to Referees
- 19 Oct 21
- Molecular Diagnosis & Therapy
-
Full paper
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2
- 18 Sep 21
- Molecular Diagnosis & Therapy
Scite analysis
Powered by scite_
1k articles received 12.4k citations see all
- 339 Supporting
- 11,718 Mentioning
- 49 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 15 Corrections
- 14 Errata
- 0 Expression of Concern
FAQs
How long has Molecular Diagnosis and Therapy been actively publishing?
Molecular Diagnosis and Therapy has been in operation since 1996 till date.
What is the publishing frequency of Molecular Diagnosis and Therapy ?
Molecular Diagnosis and Therapy published with a Bi-monthly frequency.
How many articles did Molecular Diagnosis and Therapy publish last years ?
In 2023, Molecular Diagnosis and Therapy published 1 articles.
What is the eISSN & pISSN for Molecular Diagnosis and Therapy ?
For Molecular Diagnosis and Therapy,eISSN is 1179-2000 and pISSN is1177-1062.
What is Citescore for Molecular Diagnosis and Therapy ?
Citescore for Molecular Diagnosis and Therapy is 6.9.
What is SNIP score for Molecular Diagnosis and Therapy ?
SNIP score for Molecular Diagnosis and Therapy is 1.07.
What is the SJR for Molecular Diagnosis and Therapy ?
SJR for Molecular Diagnosis and Therapy is Q2.
Who is the publisher of Molecular Diagnosis and Therapy ?
ADIS INT LTD is the publisher of Molecular Diagnosis and Therapy.